Holen Sie sich die Stockscreener-App
7.98
6.62%
0.47
Schlusskurs vom Vortag:
$7.51
Offen:
$7.61
24-Stunden-Volumen:
2.18M
Relative Volume:
0.72
Marktkapitalisierung:
$629.52M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-8.6739
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
-34.15%
1M Leistung:
-31.09%
6M Leistung:
-29.45%
1J Leistung:
-25.93%
1-Tages-Spanne:
$7.60
$8.13
1-Wochen-Bereich:
$7.22
$12.29
52-Wochen-Spanne:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Vergleichen Sie CRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
7.99 | 591.71M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.36 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.17 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.36 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.32 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
CorMedix Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story - Yahoo Finance
Why CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Guidance And Revamping Its Leadership Structure - Yahoo Finance
CorMedix stock rises after-hours: CEO locks in chairman seat, bigger paycheck and rich severance - MSN
CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance - Stocktwits
What sentiment indicators say about CorMedix Inc. stockJuly 2025 Levels & Technical Confirmation Alerts - ulpravda.ru
Truist Securities lowers CorMedix stock price target on weaker revenue outlook By Investing.com - Investing.com South Africa
Breakout Move: Will CorMedix Inc. stock maintain growth storyDay Trade & Growth Focused Investment Plans - ulpravda.ru
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes - Yahoo Finance
Why is CorMedix stock crashing today: is it worth buying on the dip? - CryptoRank
Truist Securities lowers CorMedix stock price target on weaker revenue outlook - Investing.com Australia
CorMedix shares fall as 2026 revenue outlook disappoints (update) - MSN
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity - TipRanks
Why CorMedix stock crashed today and is it worth buying on the dip? - Invezz
Is CorMedix Inc. stock a top pick in earnings seasonJuly 2025 Analyst Calls & Stock Portfolio Risk Management - ulpravda.ru
CorMedix price target lowered to $16 from $20 at Truist - TipRanks
Will CorMedix Inc. stock maintain growth storyQuarterly Trade Report & Smart Money Movement Alerts - ulpravda.ru
CorMedix Inc. Stock (CRMD) Opinions on 2026 Revenue Guidance - Quiver Quantitative
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Benzinga
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? - Stocktwits
Is CorMedix Inc. (19KA) stock resilient in recession scenariosLong Setup & Safe Capital Investment Plans - ulpravda.ru
CorMedix shares slip after unveiling lower revenue outlook for 2026 - MSN
Why Did CRMD Stock Crash 28% Today? - Stocktwits
CEO Moves: Is CorMedix Inc. (19KA) stock resilient in recession scenariosJuly 2025 Macro Moves & Verified Swing Trading Watchlist - ulpravda.ru
CorMedix sees FY26 revenue $300M-$320M - TipRanks
Cormedix Issues Strong Preliminary Q4 Results, Updates Outlook - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance By Investing.com - Investing.com Canada
Cormedix Therapeutics announces preliminary fourth quarter and full year 2025 results - MarketScreener
CorMedix sees Q4 revenue $127M, consensus $127.52M - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance - Investing.com
Cormedix Therapeutics Announces Preliminary Fourth Quarter And Full Year 2025 Results - TradingView — Track All Markets
CorMedix reports $127 million Q4 revenue, provides 2026 outlook By Investing.com - Investing.com India
(CRMD) CorMedix Expects 2026 Revenue Range $300M to $320M, vs. FactSet Est of $435.7 - MarketScreener
CorMedix announces leadership changes with CEO taking chairman role - Investing.com
Earnings Flash (CRMD) CorMedix Posts Q4 Preliminary Net Revenue $127M, vs. FactSet Est of $128.3M - MarketScreener
CorMedix Therapeutics Announces Leadership and Board Updates - The Manila Times
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates - The Manila Times
Momentum Shift: Is CorMedix Inc stock a top momentum play2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - moha.gov.vn
Is CorMedix (CRMD) Offering Opportunity After Recent Share Price Pullback? - simplywall.st
Can CorMedix Inc. (19KA) stock surprise with quarterly resultsInsider Trading Compliance & Fast Growing Trading Plans - ulpravda.ru
OTLK Stock Crashes 67% in a Week: Here's What You Need to Know - Finviz
Will CorMedix Inc. (19KA) stock benefit from infrastructure bill2026 world cup usa national team semifinals defensive leaders pressing system knockout prediction breakdown - ulpravda.ru
CorMedix (CRMD) upgraded to strong buy: Here's what you should know - MSN
Trading the Move, Not the Narrative: (CRMD) Edition - Stock Traders Daily
Is CorMedix Inc stock a top momentum play2025 Market Sentiment & Real-Time Price Movement Reports - moha.gov.vn
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 - Finviz
Assessing CorMedix (CRMD) Valuation After Its Recent Share Price Momentum - simplywall.st
Cormedix director Dunton sells $260k in shares - Investing.com
Cormedix Inc (CRMD) Live Share Price, Invest From India - INDmoney
INSM Stock Up 78% in 6 Months: Here's What You Need to Know - Finviz
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):